Omega Reports Q4 Revenue of $319.22M, Beating Consensus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4d ago
0mins
Should l Buy OHI?
Reports Q4 revenue $319.22M, consensus $268.01M. Taylor Pickett, Omega's Chief Executive Officer, stated, "We are pleased with our fourth quarter results, as we continued to grow FAD per share, while reducing leverage to the lowest level in the company's history."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OHI
Wall Street analysts forecast OHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OHI is 46.44 USD with a low forecast of 42.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 45.570
Low
42.00
Averages
46.44
High
50.00
Current: 45.570
Low
42.00
Averages
46.44
High
50.00
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Omega Healthcare Investors Reports Strong Q4 2025 Earnings and Guidance
- Strong Financial Performance: Omega Healthcare Investors reported fourth-quarter adjusted funds from operations (AFFO) of $0.80 per share, with over 8% year-over-year growth primarily driven by $1.1 billion in capital deployment, showcasing the company's success in acquisitions and active portfolio management.
- Significant Revenue Growth: The fourth-quarter revenue rose to $319 million from $279 million in the same period of 2024, with net income reaching $172 million, reflecting the company's robust performance and enhanced profitability in the market.
- Optimized Asset Management: The company closed two RIDEA transactions totaling $80 million during the quarter and made its initial investment in Canada, further strengthening its positioning and competitiveness in the North American market.
- Positive Future Outlook: The CFO provided 2026 AFFO guidance of $3.15 to $3.25 per share, anticipating continued growth through new investments and asset sales, demonstrating the company's confidence in future market opportunities.
See More
Omega Healthcare Investors Q4 Earnings Beat Expectations
- Strong Earnings Performance: Omega Healthcare Investors reported fourth-quarter earnings that exceeded market expectations, with specific figures undisclosed, but analysts believe this will boost investor confidence and drive stock price appreciation.
- Solid Guidance Outlook: The company provided an impressive financial outlook for the future, indicating continued stable revenue growth, which not only enhances market recognition of its long-term investment value but may also attract more institutional investors.
- Competitive Market Advantage: Compared to other healthcare REITs, Omega Healthcare demonstrates superior operational efficiency and asset management, which is expected to further solidify its leadership position in the industry and increase market share.
- Increased Investor Confidence: Following the earnings beat and robust guidance, investor confidence in Omega Healthcare has significantly improved, potentially leading to a positive stock price reaction in the short term and further driving the company's market capitalization growth.
See More
Omega Healthcare Reports Strong Q4 2025 Earnings and Revenue
- Strong Earnings: Omega Healthcare's adjusted FFO per share for Q4 2025 reached $0.80, exceeding analyst expectations of $0.78, and showing an increase from $0.79 in Q3 and $0.74 a year ago, indicating sustained profitability.
- Revenue Growth: The company reported Q4 revenue of $317.2 million, surpassing the consensus estimate of $268 million, and up from $311.6 million in the previous quarter and $279.3 million a year ago, reflecting robust market performance.
- Active Investment: Omega completed $334 million in new investments during the quarter, including $52 million in real estate acquisitions and $266 million in unconsolidated entity investments, demonstrating a proactive approach to business expansion.
- Solid Operating Metrics: Despite rising costs, Omega's operating metrics remain strong, with the CEO highlighting a robust balance sheet and cost of capital that will enable continued accretive investments, ensuring future growth potential.
See More
Omega Healthcare Investors Set to Announce Q4 Earnings on February 4th
- Earnings Announcement: Omega Healthcare Investors is set to announce its Q4 earnings on February 4th after market close, with consensus FFO estimate at $0.78 and revenue at $268.01 million, indicating significant market interest in its financial performance.
- Strong Operating Metrics: Despite raising its full-year guidance last quarter, CEO Taylor Pickett emphasized that operating metrics remain robust, with improving occupancy and coverage, showcasing the company's competitive edge and investment capacity in the market.
- Rating Downgrade Impact: Wells Fargo downgraded OHI, citing concerns over earnings revisions following Genesis, expected higher dispositions, and MA/Medicaid worries, suggesting that valuation may be full and potentially pressuring the stock price.
- Investor Confidence: Despite the downgrade, the average sell-side analysts and Seeking Alpha authors maintain a “Buy” rating on OHI, reflecting confidence in its long-term investment value amid the secular trend of population aging.
See More
Omega Healthcare Declares Cash Dividend
- Dividend Declaration: Omega Healthcare Investors, Inc. announced a cash dividend of $0.67 per share, payable on February 17, 2026, reflecting the company's stability and profitability in the long-term healthcare sector.
- Record Date for Shareholders: The dividend will be paid to common stockholders of record as of the close of business on February 9, 2026, ensuring timely returns for investors and boosting shareholder confidence.
- Investment Focus: As a real estate investment trust, Omega specializes in the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, demonstrating its expertise and adaptability to market demands in healthcare.
- Portfolio Distribution: The company's asset portfolio spans all regions within the US and the UK, utilizing a triple-net lease structure that enhances its risk management capabilities in diversified investments.
See More
Omega Healthcare Declares Cash Dividend
- Dividend Declaration: Omega Healthcare Investors, Inc. announced a cash dividend of $0.67 per share, payable on February 17, 2026, reflecting the company's stability and profitability in the long-term healthcare sector.
- Record Date for Shareholders: The dividend will be recorded for shareholders as of the close of business on February 9, 2026, reinforcing the company's commitment to shareholder returns and boosting investor confidence.
- Investment Focus: As a real estate investment trust, Omega focuses on the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, indicating its strategic positioning in the healthcare market.
- Asset Portfolio Structure: The company's asset portfolio is operated by a diverse group of healthcare companies predominantly under a triple-net lease structure, covering regions across the US and the UK, showcasing its extensive market presence and risk diversification capabilities.
See More
Omega Healthcare Investors Reports Strong Q4 2025 Earnings and Guidance
- Strong Financial Performance: Omega Healthcare Investors reported fourth-quarter adjusted funds from operations (AFFO) of $0.80 per share, with over 8% year-over-year growth primarily driven by $1.1 billion in capital deployment, showcasing the company's success in acquisitions and active portfolio management.
- Significant Revenue Growth: The fourth-quarter revenue rose to $319 million from $279 million in the same period of 2024, with net income reaching $172 million, reflecting the company's robust performance and enhanced profitability in the market.
- Optimized Asset Management: The company closed two RIDEA transactions totaling $80 million during the quarter and made its initial investment in Canada, further strengthening its positioning and competitiveness in the North American market.
- Positive Future Outlook: The CFO provided 2026 AFFO guidance of $3.15 to $3.25 per share, anticipating continued growth through new investments and asset sales, demonstrating the company's confidence in future market opportunities.
See More
Omega Healthcare Investors Q4 Earnings Beat Expectations
- Strong Earnings Performance: Omega Healthcare Investors reported fourth-quarter earnings that exceeded market expectations, with specific figures undisclosed, but analysts believe this will boost investor confidence and drive stock price appreciation.
- Solid Guidance Outlook: The company provided an impressive financial outlook for the future, indicating continued stable revenue growth, which not only enhances market recognition of its long-term investment value but may also attract more institutional investors.
- Competitive Market Advantage: Compared to other healthcare REITs, Omega Healthcare demonstrates superior operational efficiency and asset management, which is expected to further solidify its leadership position in the industry and increase market share.
- Increased Investor Confidence: Following the earnings beat and robust guidance, investor confidence in Omega Healthcare has significantly improved, potentially leading to a positive stock price reaction in the short term and further driving the company's market capitalization growth.
See More
Omega Healthcare Reports Strong Q4 2025 Earnings and Revenue
- Strong Earnings: Omega Healthcare's adjusted FFO per share for Q4 2025 reached $0.80, exceeding analyst expectations of $0.78, and showing an increase from $0.79 in Q3 and $0.74 a year ago, indicating sustained profitability.
- Revenue Growth: The company reported Q4 revenue of $317.2 million, surpassing the consensus estimate of $268 million, and up from $311.6 million in the previous quarter and $279.3 million a year ago, reflecting robust market performance.
- Active Investment: Omega completed $334 million in new investments during the quarter, including $52 million in real estate acquisitions and $266 million in unconsolidated entity investments, demonstrating a proactive approach to business expansion.
- Solid Operating Metrics: Despite rising costs, Omega's operating metrics remain strong, with the CEO highlighting a robust balance sheet and cost of capital that will enable continued accretive investments, ensuring future growth potential.
See More
Omega Healthcare Investors Set to Announce Q4 Earnings on February 4th
- Earnings Announcement: Omega Healthcare Investors is set to announce its Q4 earnings on February 4th after market close, with consensus FFO estimate at $0.78 and revenue at $268.01 million, indicating significant market interest in its financial performance.
- Strong Operating Metrics: Despite raising its full-year guidance last quarter, CEO Taylor Pickett emphasized that operating metrics remain robust, with improving occupancy and coverage, showcasing the company's competitive edge and investment capacity in the market.
- Rating Downgrade Impact: Wells Fargo downgraded OHI, citing concerns over earnings revisions following Genesis, expected higher dispositions, and MA/Medicaid worries, suggesting that valuation may be full and potentially pressuring the stock price.
- Investor Confidence: Despite the downgrade, the average sell-side analysts and Seeking Alpha authors maintain a “Buy” rating on OHI, reflecting confidence in its long-term investment value amid the secular trend of population aging.
See More
Omega Healthcare Declares Cash Dividend
- Dividend Declaration: Omega Healthcare Investors, Inc. announced a cash dividend of $0.67 per share, payable on February 17, 2026, reflecting the company's stability and profitability in the long-term healthcare sector.
- Record Date for Shareholders: The dividend will be paid to common stockholders of record as of the close of business on February 9, 2026, ensuring timely returns for investors and boosting shareholder confidence.
- Investment Focus: As a real estate investment trust, Omega specializes in the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, demonstrating its expertise and adaptability to market demands in healthcare.
- Portfolio Distribution: The company's asset portfolio spans all regions within the US and the UK, utilizing a triple-net lease structure that enhances its risk management capabilities in diversified investments.
See More
Omega Healthcare Declares Cash Dividend
- Dividend Declaration: Omega Healthcare Investors, Inc. announced a cash dividend of $0.67 per share, payable on February 17, 2026, reflecting the company's stability and profitability in the long-term healthcare sector.
- Record Date for Shareholders: The dividend will be recorded for shareholders as of the close of business on February 9, 2026, reinforcing the company's commitment to shareholder returns and boosting investor confidence.
- Investment Focus: As a real estate investment trust, Omega focuses on the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, indicating its strategic positioning in the healthcare market.
- Asset Portfolio Structure: The company's asset portfolio is operated by a diverse group of healthcare companies predominantly under a triple-net lease structure, covering regions across the US and the UK, showcasing its extensive market presence and risk diversification capabilities.
See More
